Stockreport

Immunome, Inc. (IMNM) Sets Sights on $1B Opportunity amid Pipeline Development [Yahoo! Finance]

Immunome, Inc.  (IMNM) 
PDF Clay Siegall reiterated heightened focus on building an oncology-focused pipeline centered on cell-surface-targeting agents and small molecules. Immunome, Inc. (IMNM) [Read more]